Affitech granted General Electric's GE Healthcare Life Sciences unit exclusive, worldwide rights to market Affitech's recombinant Protein L products

Affitech A/S

Denmark / Small-Cap Biopharma (<$1 billion)

$26.4m on 10/21/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

General Electric Co.

U.S. / Medical Devices and Diagnostics

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced